Voyager Therapeutics, Inc. revenue breakdown overview

Voyager Therapeutics, Inc. revenue for the last year amounted to 80.00 M USD, the most of which — 80.00 M USD — came from its highest performing source at the moment, Genetic Medicine, the year earlier bringing 250.01 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Voyager Therapeutics, Inc. 80.00 M USD, and the year before that — 250.01 M USD.